Concepedia
Statistics
Publications
8
Citations
353
H-Index
Active since
2016
Affiliations
Inserm(Current)
Université Paris Cité
Délégation Paris 5
Hôpital Ambroise-Paré
Fédération Francophone de Cancérologie Digestive
Ralyath Balogoun is an author at Inserm specializing in colorectal cancer, oncology, and medicine.
Publications per year
2016–2019
Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With<i>RAS</i>and<i>BRAF</i>Mutational Status
Hampig Raphaël Kourié, Jean‐François Emile, Karine Le Malicot et al. · JAMA Oncology · 2017 · 81 citations · Full text
Medicine, Oncology, Pharmacology +17
CDX2 prognostic value in stage II/III resected colon cancer is related to CMS classification
Camilla Pilati, Ralyath Balogoun, Laëtitia Marisa et al. · Annals of Oncology · 2017 · 64 citations
Medicine, Oncology, Pathology +13
Adjuvant FOLFOX +/− cetuximab in fullRAS andBRAF wildtype stage III colon cancer patients
Ralyath Balogoun, Karine Le Malicot, Josep Tabernero et al. · Annals of Oncology · 2016 · 51 citations · Full text
Medicine, Oncology, Pharmacology +12
The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer
Delphine Le Corre, Alexandre Ghazi, Ralyath Balogoun et al. · EBioMedicine · 2019 · 50 citations · Full text
Life Sciences, Cell Biology, Oncology +17
ERBB2 alterations a new prognostic biomarker in stage III colon cancer from a FOLFOX based adjuvant trial (PETACC8)
Pierre Laurent‐Puig, Ralyath Balogoun, Anne Cayre et al. · Annals of Oncology · 2016 · 46 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 8